Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Farshid Dayyani

Showing results (11-20 of 115) with videos related to

Pageof 12
Sort By:
Journal of Gastrointestinal Oncology|May 14, 2020
Predictors of outcomes in patients with gastric cancer treated with contemporary multimodality strategies-a single institution experienceTuyen Hoang, Michelle Park, Darryl Hiyama, et al.
Cureus|September 7, 2023
Partial Reversal of Anosmia Following Platinum-Based Chemotherapy in a Patient With Colorectal AdenocarcinomaAditya Mahadevan, Armon Azizi, Naveen Bhandarkar, et al.
Journal of Gastrointestinal Oncology|March 17, 2020
Gene mutations distinguishing gastric from colorectal and esophageal adenocarcinomasTuyen Hoang, Anand K Ganesan, Darryl Hiyama, et al.
Cancer Treatment Reviews|January 15, 2023
Second-line treatment options for patients with metastatic pancreatic ductal adenocarcinoma: A systematic literature reviewFarshid Dayyani, Teresa Macarulla, Andrew Johnson, et al.
Journal of the National Cancer Institute|September 16, 2011
Novel therapies for metastatic castrate-resistant prostate cancerFarshid Dayyani, Gary E Gallick, Christopher J Logothetis, et al.
British Journal of Haematology|September 6, 2003
Treosulfan is an effective inducer of cell death in myeloma cell lines and primary myeloma cells from patientsGerold Meinhardt, Farshid Dayyani, Bernd Jahrsdörfer, et al.
British Journal of Cancer|March 10, 2017
Carcinoembryonic antigen and cytokeratin-19 fragments for assessment of therapy response in non-small cell lung cancer: a systematic review and meta-analysisStefan Holdenrieder, Birgit Wehnl, Karina Hettwer, et al.
Blood|May 27, 2004
The HMG-CoA reductase inhibitor simvastatin overcomes cell adhesion-mediated drug resistance in multiple myeloma by geranylgeranylation of Rho protein and activation of Rho kinaseRalf Schmidmaier, Philipp Baumann, Meral Simsek, et al.
Leukemia Research|August 4, 2016
TLE4 regulation of wnt-mediated inflammation underlies its role as a tumor suppressor in myeloid leukemiaThomas H Shin, Christopher Brynczka, Farshid Dayyani, et al.
The American Journal of the Medical Sciences|November 22, 2007
Multicentric Castleman's disease masquerading as HIV-related lymphomaFarshid Dayyani, Liron Pantanowitz, Tom G Sandridge, et al.
Pageof 12

Showing results (11-20 of 115) with videos related to

Sort By:
Pageof 12
Journal of Gastrointestinal Oncology|May 14, 2020
Predictors of outcomes in patients with gastric cancer treated with contemporary multimodality strategies-a single institution experienceTuyen Hoang, Michelle Park, Darryl Hiyama, et al.
Cureus|September 7, 2023
Partial Reversal of Anosmia Following Platinum-Based Chemotherapy in a Patient With Colorectal AdenocarcinomaAditya Mahadevan, Armon Azizi, Naveen Bhandarkar, et al.
Journal of Gastrointestinal Oncology|March 17, 2020
Gene mutations distinguishing gastric from colorectal and esophageal adenocarcinomasTuyen Hoang, Anand K Ganesan, Darryl Hiyama, et al.
Cancer Treatment Reviews|January 15, 2023
Second-line treatment options for patients with metastatic pancreatic ductal adenocarcinoma: A systematic literature reviewFarshid Dayyani, Teresa Macarulla, Andrew Johnson, et al.
Journal of the National Cancer Institute|September 16, 2011
Novel therapies for metastatic castrate-resistant prostate cancerFarshid Dayyani, Gary E Gallick, Christopher J Logothetis, et al.
British Journal of Haematology|September 6, 2003
Treosulfan is an effective inducer of cell death in myeloma cell lines and primary myeloma cells from patientsGerold Meinhardt, Farshid Dayyani, Bernd Jahrsdörfer, et al.
British Journal of Cancer|March 10, 2017
Carcinoembryonic antigen and cytokeratin-19 fragments for assessment of therapy response in non-small cell lung cancer: a systematic review and meta-analysisStefan Holdenrieder, Birgit Wehnl, Karina Hettwer, et al.
Blood|May 27, 2004
The HMG-CoA reductase inhibitor simvastatin overcomes cell adhesion-mediated drug resistance in multiple myeloma by geranylgeranylation of Rho protein and activation of Rho kinaseRalf Schmidmaier, Philipp Baumann, Meral Simsek, et al.
Leukemia Research|August 4, 2016
TLE4 regulation of wnt-mediated inflammation underlies its role as a tumor suppressor in myeloid leukemiaThomas H Shin, Christopher Brynczka, Farshid Dayyani, et al.
The American Journal of the Medical Sciences|November 22, 2007
Multicentric Castleman's disease masquerading as HIV-related lymphomaFarshid Dayyani, Liron Pantanowitz, Tom G Sandridge, et al.
Pageof 12